Objective: The purpose of this study was to determine if lycopene and b-carotene are bioavailable from lycopene red carrots and if lycopene absorption is affected by carrot fiber. Design: Two crossover studies in humans attempted to compare the relative bioavailability of lycopene and b-carotene from tomato paste to a genetically selected lycopene red carrot during chronic feeding. Each study contained three treatment groups. The vehicle of administration was muffins. Intervention and methods: Study 1 (n¼9) used white carrots (0 mg lycopene/day), red carrots (5 mg/day), and tomato paste (20 mg/day). Study 2 (n¼10) used red carrots (2.6 mg/day), tomato paste (5 mg/day), and tomato paste plus white carrots (5 mg/day). Each intervention lasted 11 days with a 10-day washout period between treatments. Serum lycopene and bcarotene were measured by HPLC. Results: Statistical analysis indicated a significant effect of muffin type in study 1 (Po0.001), and a significant treatment by sequence interaction in study 2 (P¼0.04). The response to increasing amounts of lycopene is linear at the levels fed in these studies (r¼0.94). The data suggest that maintenance of serum lycopene concentrations at 0.3 mmol/l occurs at about 2 mg/day of lycopene from mixed dietary sources and a serum plateau occurs at Z20 mg/day. Conclusions: These results show that lycopene and b-carotene are bioavailable from red carrots and lycopene absorption seems to be affected by carrot fiber. Making inferences from both studies, the lycopene in the red carrot is about 44% as bioavailable as that from tomato paste. Red carrots provide an alternative to tomato paste as a good dietary source of lycopene and also provide bioavailable b-carotene.
Introduction
Lycopene is a carotenoid responsible for the red pigment seen in tomatoes, pink grapefruit, and watermelon. The primary dietary source of lycopene is the tomato, with 85% coming from tomato products in the US (Arab & Steck, 2000) . Lycopene, while having no provitamin A activity, is a potent antioxidant with twice the activity of b-carotene for quenching singlet oxygen and 10 times the in vitro antioxidant activity of a-tocopherol (DiMascio et al, 1989; Shi & Le Mague, 2000) . Epidemiological evidence suggests an inverse association between dietary lycopene and the development of certain types of cancer (Agarwal & Rao, 2000) . This association is especially strong for prostate cancer, but epidemiological studies have also found an inverse relationship with bladder, cervical, and breast cancers as well as cancers of the gastrointestinal tract (Burney et al, 1989; Helzlsouer et al, 1989; van Eenwyk et al, 1991; Giovannucci et al, 1995; Paetau et al, 1998) . The discovery of large concentrations of lycopene in specific tissues in the body suggests that lycopene may play a specific role in such tissues, which include the plasma, testes, adrenal glands, liver, and kidney (Stahl & Sies, 1996) . However, before the body can utilize lycopene, it must be absorbed through the intestine, and very little information is known about factors that affect lycopene bioavailability.
Bioavailability is defined as the fraction of carotenoid that is absorbed by the body and available for use in physiologic functions (Tanumihardjo, 2002) . This absorption is influenced by many dietary factors and food properties. Specifically for lycopene, these factors include: the amount of lycopene consumed, food matrix, dietary fiber and fat, interactions with other carotenoids, and interference with proper micelle formation (Castenmiller & West, 1998; Shi & Le Mague, 2000; van Het Hof et al, 2000; Tanumihardjo, 2002) . Studies have indicated that the bioavailability of the cis-isomer of lycopene is greater than the all-trans isomer and heat processing improves bioavailability by increasing the cis-to trans-ratio (Stahl & Sies, 1996; Shi & Le Mague, 2000) . Mechanical processing of tomato products, which helps to break down cell walls and release lycopene from the food matrix, also increases bioavailability (Hill & Rogers, 1969; Helzlsouer et al, 1989) . Carotenoid bioavailability is decreased by dietary fiber (Erdman et al, 1986) and increased by the presence of fat (De Pee & West, 1996; van Het Hof et al, 2000) . Bioavailability of lycopene is also affected by the amount of lycopene administered, as well as the presence of other carotenoids (De Pee & West, 1996; van Den Berg, 1999; Tanumihardjo, 2002) .
In these experiments, we sought to gain information on the bioavailability of lycopene and b-carotene from 'red' carrots. Our goal was to determine the relative bioavailability of lycopene from a genetically selected high lycopene carrot in relationship with tomato paste. We conducted two human feeding trials to compare the bioavailability of differing levels of lycopene from a genetically selected high lycopene red carrot or from tomato paste. Given that mechanical and heat processing increase bioavailability and fiber decreases absorption, we expected higher bioavailability of lycopene from the tomato paste as compared to the carrot due to the greater amount of processing and matrix disruption in the tomato paste. In addition, we also looked at the effect of carrot fiber on lycopene absorption from tomato paste, and expected less absorption of lycopene as a result of the carrot fiber.
Subjects and methods

Subjects
Two studies were conducted. Nine subjects, five females and four males participated in study 1 and 10 subjects, five females and five males, participated in study 2. The age range of the subjects was 20-32 y. All subjects were recruited from university staff and students via email and posters. Subjects were all healthy, nonsmoking adults who were free from metabolic diseases such as diabetes mellitus or thyroid problems. Basic anthropometric measurements were obtained and BMIs calculated (Table 1) . Subjects were not included if their diet contained any strict restrictions, for example, vegetarian or vegan. Informed consent was obtained from all subjects, and they voluntarily agreed to the conditions of the study, including abstinence from alcohol use before and during treatment periods. The Institutional Review Boards at the University of Wisconsin-Madison College of Agriculture and the School of Medicine approved the protocol and informed consent forms.
Experimental design
Study 1: Subjects were placed on a low carotenoid diet 1 week prior to the beginning of the study and remained on this diet throughout the study. A list of 31 fruits and vegetables to eliminate and foods containing those processed fruits and vegetables was provided to each subject and determined using the USDA carotenoid database (accessed February 2002) . Specifically, lycopene-containing foods on the list included all tomato products, pink and red grapefruit, apricots, and watermelon. Beginning on day 0 of the intervention, subjects were randomized into three groups. For study 1, the treatments consisted of white carrot muffins which contained 0 mg lycopene and 0 mg bcarotene (WC1), red carrot (2001 harvest) muffins at 5 mg lycopene and 2 mg b-carotene (RC1), and tomato paste muffins at 20 mg lycopene and 0.24 mg b-carotene (TP1). In study 2, subjects were divided into one of the three treatments: red carrot (2002 harvest) at 2.6 mg lycopene and 1.4 mg b-carotene (RC2), tomato paste at 5 mg lycopene and 0.12 mg b-carotene (TP2), and white carrot plus tomato paste at 5 mg lycopene and 0.12 mg b-carotene (WTP2). In both studies, subjects were fed the carrots in the form of two muffins per day for 11 days (days 0-10), with a 10-day washout period (days 11-20) before the start of the next treatment period. To ensure that muffins were consumed, subjects reported to the research kitchen between 0700 and 0900 throughout the study to eat a breakfast consisting of the treatment muffins (2/day), yogurt (regular, not fat free), fruit, and coffee, tea or juice. In addition, subjects were asked to keep a daily fruit and vegetable diary throughout the study, which allowed us to monitor outside carotenoid intake. Fasting blood samples were taken on days 0, 1, 3, 5, 7, 9, 11, 13, and 15 in study 1; and on days 0, 1, 2, 4, 7, 9, 11, 14, and 16 in study 2. Subjects then crossed over into another treatment group (Table 2 ) until all three treatments were completed. 
Carrots and muffins
The red and white carrots were obtained from Dr Philipp Simon in the Horticulture Department at the University of Wisconsin-Madison. These carrots were genetically selected to have high levels of lycopene or to be void of all carotenoids according to methods previously published (Simon et al, 1989; Simon, 1997) . The muffin recipes for study 1 were developed to maximize the amount of carrot and tomato paste while maintaining palatability. Thus, in study 1, the red and white carrot muffins were equal in fat (7 g/muffin) and fiber content (1.5 g/muffin) while the tomato paste muffins contained four times the lycopene of RC1 and more fat (11 g/muffin). In study 2, we attempted to control for the lycopene content to deliver 5 mg/day as in the red carrot group of study 1, and all muffins were equal in fiber and fat content. However, the 2002 harvest of the lycopene red carrot did not contain the same amount of lycopene per carrot as the harvest of 2001. Unfortunately, carrots were shipped directly from California and arrived the day before the study started and therefore we did not realize this seasonal difference upon study commencement. Therefore, the red carrot muffin (RC2) contained less lycopene than either the tomato paste muffin (TP2) or the tomato paste plus white carrot muffin (WTP2). All carrots were cleaned and shredded using a food processor before adding to the muffins. All muffins were made to look as similar as possible by adding red food coloring to the white carrot muffins to mimic the appearance of the other muffins. Muffins were stored frozen for up to 8 days. All food preparations were performed in the research kitchen in the Department of Nutritional Sciences at UW-Madison. The lycopene concentration of the muffins was determined by grinding 1 g of material after homogenization in a mortar and pestle with anhydrous sodium sulfate and exhaustively extracting with alternate washes of dichloromethane and acetone. b-Apo-8 0 -carotenyl decanoate (5.3 nmol) was added as an internal standard before extraction. b-Apo-8 0 -carotenyl decanoate was synthesized by reducing b-apo-8 0 -carotenal to b-apo-8 0 -carotenol with sodium borohydride and then esterifying with decanoic anhydride under basic conditions using triethylamine (Barua & Furr, 1992) . The E 1 cm 1% for b-apo-8 0 carotenol (MW¼418.7) is 2690 at 426 nm (Barua & Olson, 2000) . The volume of the extract was taken up to 100 ml and an aliquot measured by HPLC as described below.
Preparation of serum
Blood samples were collected in Vacutainer brand bloodcollection tubes with a serum separator (Becton Dickson, Franklin Lakes, NJ, USA). Tubes were protected from light and allowed to clot for 30 min. Samples were centrifuged for 15 min at 3300 Â g. Serum was stored in 4 ml Cryotubes (Corning Inc., Corning, NY, USA) with two 100 ml aliquots portioned into separate 2 ml vials (Perfector Scientific, Atascadae, CA, USA) for analysis. The atmosphere in the tubes was replaced with argon and serum was stored at -801C until analysis. All serum preparation and analyses were conducted under yellow lighting to protect carotenoids from isomerization and photodegradation with white light. To prepare serum for analysis (Kostic et al, 1995) , 45 ml of internal standard solution (0.17 nmol b-apo-8 0 -carotenyl decanoate) in isopropanol was added along with 100 ml dichloroethane (Fisher Scientific, Brightwaters, NY, USA), and 155 ml isopropanol (Fisher Scientific, Brightwaters, NY, USA) to the 2 ml sample vial. Samples were vortexed for 30 s and centrifuged for 10 min at 14 000 Â g. The supernatant was transferred with a pipette and placed into HPLC vials (Waters Corp., Milford, MA, USA) for analysis.
HPLC analysis
Serum and muffins were analyzed on a Waters HPLC: 600 solvent delivery system in isocratic mode, 717 autosampler, and a 996 photodiode array detector. The detector was set in scan mode, 210-550 nm, during the analysis and the wavelength of detection for quantification against authentic standards was 450 nm, which is a compromise for l maxima of 426 nm for b-apo-8 0 -carotenyl decanoate, 453 nm for bcarotene and 472 nm for lycopene. The column was a Waters Resolvet C 18 5 mm column, 3.9 Â 300 mm 2 . The mobile phase was modified from Kostic et al (1995) and consisted of 85:10:5 by volume acetonitrile, methanol, and dichloroethane, with 0.1% triethylamine and 10 mmol/l ammonium acetate (Fisher Scientific, Brightwaters, NY, USA). A volume of 100 ml of the prepared serum was injected, and the run time was 23 min. Serum concentrations of lycopene and b-carotene identified by HPLC were corrected by the recovery of the internal standard. The extraction efficiency ranged from 78 to 105%. The CVs for serum and food carotenoids run on the same day were 2 and 4%, respectively. All samples from the same individual for each treatment were run in the same day.
Statistical analysis
The serum concentration of the carotenoid was plotted vs time and the area under the curve (AUC) was calculated for lycopene and b-carotene by trapezoidal approximation. A split-plot ANOVA was conducted with fixed-effect terms for sequence, carrot, and interaction, and a random-effects term for subjects. We analyzed an effect of treatment (carrot muffin type), sequence (order of muffins), gender, BMI, and age. The data from each study were analyzed separately. The data were not pooled because different individuals completed each study and large interindividual variability occurs with carotenoid absorption. Po0.05 was considered significant. Linear regression was used to evaluate the dose response to increasing amounts of total lycopene and bcarotene.
Results
Subject compliance
Nine subjects participated in study 1 (44% males) and 10 subjects in study 2 (50% males). One female left study 1 voluntarily due to a time constraint on her part and therefore is missing from analysis of group RC1. One female was removed from study 2 after completing treatment TP2 because it was discovered that she did not follow the lowcarotenoid diet during the second treatment. In general, compliance with the low-carotenoid diet appeared to be high, with exception of the subject that was removed. The food diaries in both studies and the white carrot group in study 1 indicated that subjects were highly compliant with the low-carotenoid diet.
Carotenoid concentration Means (7s.d.) for the AUC for lycopene and b-carotene were calculated (Table 3 ). The serum concentrations for lycopene and b-carotene in both studies were corrected by subtracting the baseline concentration from the posttreatment value and then determining the mean increase or decrease at each time point. Similar to other studies of this type, the serum response to carotenoid feeding was highly variable between subjects, with some subjects responding to lycopene supplementation while others did not respond well to any of the treatments (Brown et al, 1989) . The response to treatment with lycopene was not correlated to the baseline concentration for either study (PX0.33).
Study 1
Study 1 contained three treatment groups: WC1 (0 mg lycopene/day), RC1 (5 mg lycopene/day), and TP1 (20 mg lycopene/day). As expected, the tomato paste muffins resulted in the largest increase in serum lycopene with a 140% increase above baseline by day 11 of the treatment period. The lycopene concentration was still elevated by day 15, and did not return to baseline by the beginning of the next treatment period for all individuals. Treatment with RC1 (5 mg/day) resulted in a smaller increase in serum lycopene of 28% above baseline as measured on day 11 of the treatment ( Figure 1 ). As expected, WC1, which was void of all carotenoids, resulted in a decrease of 37% by day 11 from the initial baseline serum lycopene concentration, which then leveled off and did not decrease more by day 15 (Figure 1 ). Statistical analysis of serum lycopene showed a strong effect of treatment, with all treatment types significantly different from the other (Po0.001 between RC1 and TP1, and between TP1 and WC1; P¼0.022 between RC1 and WC1). There was no significant effect of sequence, gender, BMI, or age. To determine if the serum lycopene concentration began to reach a saturation point by the presence of a plateau, a broken-line regression model was fit to each individual's serum lycopene over time and compared to the linear regression model. After treatment with TP1 (20 mg/ day), four of nine subjects did begin to show a significant (n¼3) or approaching significant (n¼1) plateau (Po0.001 to 0.06). These data are not shown.
The results for b-carotene show a greater increase in serum concentration in response to treatment with the red carrot than with the tomato paste muffin mostly due to the vast difference in b-carotene concentrations between the two treatments. Treatment with RC1 (2 mg b-carotene) resulted in an increase above baseline of 18%, while treatment with TP1 (0.24 mg) resulted in a decrease of 7% by day 11, and continued to decrease until day 15 where it was 19% below Table 3 AUC (mmol day/l) for the serum response, corrected for baseline concentration, and percent (%) change at 11 days after chronic feeding to humans for lycopene and b-carotene for each muffin type and study baseline concentrations (Figure 2a ). Similar to the serum response for lycopene, treatment with WC1 (0 mg) also resulted in a decrease in serum b-carotene concentration of 22%. There was no evidence of a significant effect for any covariate (gender, BMI, age, or sequence) but a trend towards a difference between RC1 and WC1 (P¼0.08). There was also a trend towards a negative association between b-carotene concentration and BMI, where persons with larger BMIs had a smaller serum response.
Study 2
The largest elevation in serum lycopene resulted during treatment with TP2 (5 mg lycopene/day), with an increase above baseline of 45% by day 11. The WTP2 muffin (5 mg lycopene/day), having the same lycopene level as TP2 but the same type of fiber as the carrot muffins, resulted in a 35% increase above baseline for serum lycopene (Figure 3 ). Treatment with RC2 (2.6 mg lycopene/day) resulted in a net decrease of 7% from baseline concentrations as measured on day 11 because of carryover from a prior treatment. The statistical analysis for study 2 showed a significant treatment by sequence interaction (P¼0.04) for serum lycopene. This indicates that the serum response to each treatment was dependent on the order they were administered. The lycopene levels during treatment with RC2 were lowest in Group 1, which received that muffin first. The lycopene levels during the WTP2 muffin were lowest in Group 2, who received that muffin treatment first. Treatment with TP2, however, resulted in similar lycopene levels for all treatment groups, regardless of which order it was administered. Thus, it appears that RC2 and WTP2 treatments depend on whether or not the treatment is administered as the initial treatment or as one of the latter treatments. To eliminate the sequence by treatment interaction and solely analyze for an effect of treatment, the results from the first period of the study were analyzed alone. When looking at this first period only, there was a significant effect of treatment (Pr0.05) meaning that RC2 did, in fact, increase serum lycopene concentration, and a slightly significant effect of age (P¼0.05), where the response for lycopene was lower for older individuals.
The results for serum b-carotene are similar but stronger than those seen in study 1 (Figure 2b) . Treatment with RC2 Figure 1 Study 1: Mean serum lycopene concentration (mmol/l) corrected for baseline concentration in humans fed red carrot muffins (n¼8, RC1¼5 mg lycopene/day, ') or white carrot muffins (n¼9, WC1¼0 mg lycopene/day,~) for 11 days (days 0-10). The serum response to lycopene feeding showed a strong effect of treatment (P¼0.022 between RC1 and WC1). Error bars represent s.d. Figure 2 Study 1 (a): Mean serum b-carotene concentration (mmol/l) for each treatment corrected for baseline in humans fed either red carrot muffins (n¼8, RC1¼2 mg b-carotene/day, '), tomato paste muffins (n¼9, TP1¼0.24 mg b-carotene/day, m), or white carrot muffins (n¼9, WC1¼0 mg b-carotene/day,~) for 11 days. There is a trend towards a treatment difference between RC1 and WC1 (P¼0.08). Study 2 (b): Mean serum b-carotene concentration (mmol/l) for each treatment corrected for baseline in humans fed either red carrot muffins (n¼9, RC2¼1.4 mg b-carotene/day, '), tomato paste muffins (n¼10, TP2¼0.12 mg b-carotene/day,m), or white carrot plus tomato paste muffins (n¼9, WTP2¼0.12 mg bcarotene/day,~) for 11 days. The b-carotene response of RC2 is significantly higher than TP2 and WTP2 (Po0.001). The treatment differences were found between RC2 and TP2, and RC2 and WTP2 with no difference between TP2 and the WTP2. Error bars represent s.d.
(1.4 mg b-carotene/day) resulted in a 28% increase in serum b-carotene as measured on day 11. WTP2 and TP2 (0.12 mg bcarotene/day) resulted in decreases of serum b-carotene concentration of 18 and 8%, respectively. The statistical analysis for b-carotene shows a strong effect of treatment (Po0.001), but no effect of sequence, BMI, or gender. These treatment differences were found only between RC2 and TP2, or RC2 and WTP2, but not between TP2 and WTP2. Thus, RC2 resulted in a significant increase in serum b-carotene concentration over tomato paste feeding. A marginally significant effect of age (P¼0.05) did exist, where older individuals showed a muted serum b-carotene response.
The mean serum responses in both studies 1 and 2 as measured by AUC to increasing amounts of lycopene administered is linear (r¼0.94, Figure 4 ). In addition, the xintercept suggests that to maintain serum lycopene concentrations at 0.370.05 mmol/l approximately 2 mg/day of lycopene is necessary from mixed dietary sources, that is, tomatoes and carrots. The same exercise for the mean serum response to b-carotene is also highly correlated (r¼0.83) and the x-intercept suggests that to maintain serum b-carotene at 0.1270.02 mmol/l a daily intake of 0.7 mg is necessary (but this will of course depend on vitamin A status).
Discussion
The carotenoid profile of typical orange carrots includes predominantly a-and b-carotene which are both precursors of retinol. The carotenoid profile of the specialty 'red' carrots used in this study is predominantly lycopene and b-carotene. While the ratio of a-to b-carotene seems to be fairly constant in typical orange carrots, the ratio of lycopene to b-carotene in red carrots tends to fluctuate seasonally and is partly dependent on environmental factors, that is, soil fertility, temperature, and water content.
The goals of these experiments were threefold: to determine if the lycopene present in the red carrot was bioavailable, to see if there is an effect of carrot fiber on lycopene absorption and to examine the relative bioavailability of the lycopene red carrot to tomato paste. Our hypothesis was that the lycopene from the high lycopene carrot was bioavailable, however, not as bioavailable as that from tomato paste. This hypothesis is based on studies that have indicated lycopene from processed tomato products is more bioavailable than raw tomatoes (Porrini et al, 1998; Bohm & Bitsch, 1999; Shi & Le Mague, 2000) . In addition, these experiments allow us to examine the effect of carrot fiber on lycopene absorption. Studies have shown an inhibiting effect of carrot fiber on carotenoid absorption (Erdman et al, 1986) . Thus, we expected that lycopene from the white carrot plus tomato paste muffin would have lower absorption than from the tomato paste muffin.
In general, our results support these hypotheses. The greatest increase in serum lycopene resulted after consumption of the tomato paste muffins at both 20 and 5 mg/day (Table 3 ). The red carrot muffins either resulted in an increase (5 mg/day) or maintained serum lycopene (2.6 mg/ day) depending upon the concentration and order of treatment administration. The white carrot muffin, which was void of all carotenoids, resulted in a decrease in serum lycopene concentration. In addition, WTP2 did indeed show Figure 3 Study 2: Mean serum lycopene concentration (mmol/l) corrected for baseline concentration in humans fed tomato paste muffins (n¼10, TP2¼5 mg lycopene/day, m) or white carrot plus tomato paste muffins (n¼9, WTP2¼5 mg lycopene/day, ') for 11 days. The carrot fiber had a significant negative effect on lycopene absorption from the tomato paste (Po0.05). Error bars represent s.d. Figure 4 The relative AUC of serum lycopene response to different supplementation levels of lycopene in humans fed red carrot, tomato paste, or white carrot muffins for 11 days. There is a linear response to increasing amounts of lycopene regardless of muffin type (r¼0.94). In addition, this graph suggests that to maintain lycopene concentrations in the serum at 0.3 mmol/l, approximately 2 mg/day of lycopene is necessary from mixed dietary sources, i.e. tomatoes and carrots, as calculated from the x-intercept. Error bars represent s.d. a negative effect of carrot fiber on the bioavailability of lycopene, with a smaller serum response to feeding than observed with TP2 (Po0.05). The slight decrease in serum lycopene during treatment with RC2 (2.6 mg/day) is an artifact and can be explained by a carryover effect from treatment with TP2 (5 mg/day). If the subjects who were treated with RC2 in period one (n¼3) of the study are analyzed alone, then there is an increase in serum lycopene concentration of 6% above baseline as measured on day 11 of treatment. Moreover, after 2 days the mean lycopene concentration for all periods was maintained until treatment was halted on day 11.
b-Carotene is the second most plentiful carotenoid found in red carrot and tomato paste. As we developed our recipes based on the amount of lycopene, the b-carotene treatments were much lower in the tomato paste groups. Thus, the b-carotene concentration fell during our tomato paste interventions and increased during the red carrot feeding. Moreover, the lycopene to b-carotene ratios differ between tomato paste and red carrot, which also partially explains why our experiments found a greater peak serum b-carotene concentration after treatment with red carrot. The presence of other carotenoids can either compete for or enhance absorption (van Den Berg, 1999) . Studies have found that lutein and b-carotene compete for absorption (Micozzi et al, 1992; Kostic et al, 1995; Albanes et al, 1997) ; however, the same is not necessarily true for lycopene and b-carotene. While some have shown enhanced b-carotene absorption with lycopene administration (High & Day, 1951) , others have shown either no effect or inhibition on b-carotene absorption (White et al, 1993; Johnson et al, 1997; O'Neill & Thurnham, 1998) . Therefore, the larger lycopene to b-carotene ratio present in the tomato paste may inhibit absorption of b-carotene.
The major carotenoids in the red carrot and tomato paste are lycopene and b-carotene but other carotenoids, such as acarotene and small amounts of xanthophylls, could also interfere with absorption of lycopene. Another confounding factor when analyzing and predicting bioavailability of b-carotene from foods is the conversion to retinol after absorption. True bioavailability of b-carotene could best be done by labeling vegetables with stable isotopes, carefully analyzing the amount fed in a homogeneous sample and determining the area under the concentration curve during a short interval after feeding for both retinol and b-carotene. However, these experiments are expensive and technically challenging.
In study 2, we found a weak negative association between serum b-carotene and BMI. Previous studies have shown that serum b-carotene and BMI are inversely related (Willett et al, 1983; Constantino et al, 1988; Herbeth et al, 1989; Nierenberg et al, 1989; Albanes et al, 1992) suggesting an increase in sequestration of lipophilic b-carotene by the larger amount of fat stores sometimes present in people with larger BMIs (Albanes et al, 1992) . However, our study does not support this finding, because those individuals with larger BMIs did not always have a high body fat percentage but increased lean muscle mass. In addition, this association between b-carotene and BMI was not found in the first experiment which also contained several subjects with BMIs greater than 25.
A large component of the variability in response to carotenoid feeding is individual variation. Subjects who show changes in serum carotenoid concentrations are called 'responders', while those who do not are called 'nonresponders' (De Pee & West, 1996) . Many studies report this large individual variation with b-carotene supplementation, however, fewer studies have seen this variability with lycopene. While serum lycopene was highly correlated with fruit and vegetable consumption in one study (Forman et al, 1999) , another study did not find any correlation between serum lycopene and fruit and vegetable intake (Campbell et al, 1994) . Moreover, a large variation in AUC for serum lycopene as well as a large variability in the peak serum lycopene concentration was found in response to supplementation (Johnson et al, 1997) .
Our experiments did display a large individual variation in response to lycopene supplementation. This large variability is seen regardless of the amount of lycopene supplemented. The peak serum lycopene concentration varied from 0.36 to 0.89 mmol/l during TP1 treatment (20 mg/day), and from 0.21 mmol/l to 0.54 mmol/l during RC2 (2.6 mg/day). This variability did not appear to be related to BMI or gender. In addition, the response to treatment with lycopene containing vegetables was not correlated (PZ0.33) to the pretreatment serum concentrations that has been seen with b-carotene supplementation (Albanes et al, 1992) .
The half-life of lycopene in the serum has been estimated to be between 12 and 33 days (Rock et al, 1992) . In our studies, the degree of decay was related to the peak lycopene concentration reached after treatment with red carrots or tomato paste. Including all data points and using the median value of 0.35 mmol/l at day 11, the mean % change to study completion (4 or 5 days) above and below 0.35 mmol/l is À30.0714% and À9.4733%, respectively. These values are significantly different (P¼0.006). Thus, immediately after dietary withdrawal of lycopene, the utilization rate is quite rapid when concentrations are high. For example, a subject whose peak lycopene concentration was 0.73 mmol/l at day 11 fell to 0.39 mmol/l 4 days after treatment withdrawal, a 47% decrease. The same subject during a different treatment arm had a peak lycopene concentration of 0.28 mmol/l at day 11 which fell to 0.24 mmol/l four days after treatment withdrawal, a 14% decrease. Thus, the utilization rate is higher at higher concentrations during treatment withdrawal and then drops off when the body pool of lycopene is decreased indicating that there are probably many body compartments contributing to serum lycopene during treatment withdrawal.
In study 1, WC1 and RC1 were equal in fat and fiber content, and the statistical analysis indicates that the increase in serum lycopene seen during RC1 was significantly different from WC1. Thus, we can conclude that the lycopene from the lycopene red carrot is indeed bioavailable. The peak serum lycopene concentration for TP1 (20 mg/day) is approximately four times as large as RC1 (5 mg/day). This suggests that with 20 mg of lycopene per day, absorption is linear and the saturation point in the serum has not yet been reached in all individuals (Figure 4) . Some studies suggest that there is a finite capacity of the intestine to absorb carotenoids (Bowen et al, 1993) , resulting in a plateau or maximum serum carotenoid concentration. Our statistical analysis showed that 4 of 9 subjects reached a plateau at 20 mg lycopene/day. If the duration of the intervention was lengthened, more subjects may have reached a saturation point.
In study 2, we attempted to equalize all treatment groups for lycopene content at a rate of 5 mg lycopene/day as determined from study 1. However, the red carrot harvested in 2002 was not as high in lycopene as in 2001. As a result, the muffins contained less lycopene than originally intended. Although we cannot directly compare the bioavailability of lycopene from tomato paste to that of the red carrot in study 2, we can look at the effect of carrot fiber on the absorption of the carotenoids present in the tomato paste (Figure 3 ). Statistical analysis indicated a significantly lower AUC for WTP2 (1.1571.44 mmol day/l) than TP2 (1.3971.08 mmol day/l), indicating that the carrot fiber does have a negative effect on lycopene absorption (Po0.05). This is an overall reduction of 17% in the bioavailability of the lycopene when carrot fiber is present. If we compare studies 1 and 2 where 5 mg were fed each day from the red carrot and tomato paste, respectively, and keeping in mind that the subjects were not the same, the bioavailability of the lycopene in the red carrot is about 44% of that in the tomato paste. While the carrots in these studies were processed, perhaps future studies could include evaluation of heatprocessed carrot paste or pasteurized juice on lycopene bioavailability.
Implication of the lycopene red carrot: These experiments showed that the lycopene from the lycopene red carrot is bioavailable. The lycopene red carrot could provide a dietary alternative to tomatoes as a source of lycopene. For many individuals, tomatoes are not included in their diets because they are more acidic than carrots. In addition, fresh tomatoes can be more expensive and do have a shorter shelf life. Thus, the lycopene red carrot is a viable alternative to tomatoes. The term 'functional food' has been used to describe a food that has health benefits beyond basic nutrition. Lycopene has been implicated as being protective against certain forms of cancer. As the carrot is a familiar and highly popular vegetable, the red carrot as a functional food could help increase lycopene consumption in general.
